Gotowa bibliografia na temat „Lung cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Lung cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Lung cancer"
Benkirane, Selma. "Skin metastases revealing lung cancer". Clinical Medical Reviews and Reports 2, nr 4 (10.08.2020): 01–02. http://dx.doi.org/10.31579/2690-8794/024.
Pełny tekst źródłaPazos, Claribel. "Lung cancer: prevent or treat?" Biomedical Research and Clinical Reviews 4, nr 4 (30.08.2021): 01–02. http://dx.doi.org/10.31579/2692-9406/073.
Pełny tekst źródłaParida, Sheetal, Sumit Siddharth i Dipali Sharma. "Role of Omentin in Obesity Paradox in Lung Cancer". Cancers 13, nr 2 (13.01.2021): 275. http://dx.doi.org/10.3390/cancers13020275.
Pełny tekst źródłaGarrepalli, Saritha. "Global Patterns of Lung Cancer Incidence". Cancer Research and Cellular Therapeutics 2, nr 2 (1.08.2018): 01–03. http://dx.doi.org/10.31579/2640-1053/027.
Pełny tekst źródłaSrivastava, A. N., Neema Tiwari, Shailendra Yadav i Suryakant . "LUNG CANCER STEM CELLS-AN UPDATE". Era's journal of medical research 4, nr 1 (1.06.2017): 22–31. http://dx.doi.org/10.24041/ejmr2017.4.
Pełny tekst źródłaTaylor, Jacob, Adam B. Weiner, Binhuan Wang, Arjun V. Balar, Gary D. Steinberg i Richard S. Matulewicz. "Lung Metastases Versus Second Primary Lung Cancers in Patients with Primary Urothelial Carcinoma of the Bladder: A National Population-Based Assessment". Bladder Cancer 7, nr 3 (31.08.2021): 347–54. http://dx.doi.org/10.3233/blc-210008.
Pełny tekst źródłaSankar, V., R. Kothai i N. Vanisr. "Lung Cancer - A Review". International Journal of Health Sciences and Research 13, nr 10 (26.10.2023): 307–15. http://dx.doi.org/10.52403/ijhsr.20231042.
Pełny tekst źródłaZheng, Xiaohu, Weihua Xiao i Zhigang Tian. "869 Anti-LunX targeting therapy for lung cancer". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (listopad 2020): A921. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0869.
Pełny tekst źródłaGreschuchna, D. "Surgical Treatment of Small Cell Lung Cancer". Journal of the Japanese Association for Chest Surgery 3, nr 2 (1989): 169. http://dx.doi.org/10.2995/jacsurg1987.3.2_169.
Pełny tekst źródłaDartevelle, Philippe. "Results of Carinal Resection for Lung Cancer". Journal of the Japanese Association for Chest Surgery 11, nr 3 (1997): 291. http://dx.doi.org/10.2995/jacsurg.11.291.
Pełny tekst źródłaRozprawy doktorskie na temat "Lung cancer"
Gaskin, Janet. "Radon and Lung Cancer". Thesis, Université d'Ottawa / University of Ottawa, 2019. http://hdl.handle.net/10393/39003.
Pełny tekst źródłaThomas, Akesh, zainab Fatima i Girendra resident Hoskere. "Lung Cancer in Tennessee". Digital Commons @ East Tennessee State University, 2021. https://dc.etsu.edu/asrf/2021/presentations/69.
Pełny tekst źródłaRuiz, Rossana, Marco Galvez-Nino, Ebert Poquioma, Abel Limache-García, Edgar Amorin, Mivael Olivera, Natalia Valdiviezo i in. "Lung Cancer in Peru". Elsevier Inc, 2020. http://hdl.handle.net/10757/652438.
Pełny tekst źródłaRevisión por pares
Salvati, Valentina. "Development of effective lung cancer therapies based on lung cancer stem cella targeting". Doctoral thesis, Università di Catania, 2015. http://hdl.handle.net/10761/4035.
Pełny tekst źródłaŞeşen, Mustafa Berkan. "Lung cancer assistant : a hybrid clinical decision support application in lung cancer treatment selection". Thesis, University of Oxford, 2013. https://ora.ox.ac.uk/objects/uuid:e0dd01e4-3f18-49ed-89af-5e81894d4967.
Pełny tekst źródłaTurner, Nicola Jane. "Cancer in older people : studies in lung cancer". Thesis, University of Leeds, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.399662.
Pełny tekst źródłaOLSSON, MILLA, i CAROLINE ROSELL. "Telemedicine for Lung Cancer Patients". Thesis, KTH, Skolan för datavetenskap och kommunikation (CSC), 2013. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-136951.
Pełny tekst źródłaNowadays the health care system in Sweden is faced with several challenges like shortage of space, physicians and long distances to specialized health care. A possible solution for this being discussed at the lung cancer department of Karolinska University 2 Hospital is the use of telemedicine. If implemented it would be part of the followup treatment. The objective of our research is to find out if this technology can help improve the health care. In order to investigate the opportunity for a telemedicine solution, we collected qualitative data from multiple different sources. This included two doctors specialized in lung cancer, and a focus group with nurses from Radiumhemmet. We also conducted interviews with relevant individuals outside the hospital including Nirav Desai who is the Founder and CEO of Hands On Telehealth; furthermore, we visited the Children’s Healthcare of Atlanta based in Atlanta, Georgia where telemedicine is used on a daily basis. Thanks to the carried out research, we have discovered that telemedicine could be used in certain scenarios and contribute towards a more frequent contact between the patient and the medical professionals. Thus, this new technique could help nurses execute lighter symptoms assessment remotely and reduce waiting times. We also discovered some inconveniences in a telemedicine solution designed for lung cancer patients. We personally do not think they are the best target group for such a solution since the patients are mostly the elderly with little computer experience. Also the disease is severe and requires physical examinations where the telemedicine existing today would not improve the care giving. To all intents and purposes, telemedicine might not be the only and ultimate solution for the problems identified within healthcare for lung cancer patients at Radiumhemmet, but it can work well as a supplement. 3
Basran, Parminder S. "Optimisation of lung cancer treatment". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1997. http://www.collectionscanada.ca/obj/s4/f2/dsk3/ftp04/mq22568.pdf.
Pełny tekst źródłaTinnemans, Monique Maria Franciska Johanna. "Cytokinetic analysis of lung cancer". Maastricht : Maastricht : Universitaire Pers Maastricht ; University Library, Maastricht University [Host], 1996. http://arno.unimaas.nl/show.cgi?fid=7289.
Pełny tekst źródłaRichards, Elizabeth. "Molecular profiling of lung cancer". Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24546.
Pełny tekst źródłaKsiążki na temat "Lung cancer"
Joseph, Aisner, red. Lung cancer. New York: Churchill Livingstone, 1985.
Znajdź pełny tekst źródłaA, Roth Jack, Cox James D. 1938- i Hong Waun Ki, red. Lung cancer. Boston: Blackwell Scientific Publications, 1993.
Znajdź pełny tekst źródłaHirsch, Fred R. Lung cancer. London: Remedica, 2010.
Znajdź pełny tekst źródłaGinsberg, Robert J. Lung cancer. Hamilton, Ont: BC Decker, 2002.
Znajdź pełny tekst źródłaDriscoll, Barbara. Lung Cancer. New Jersey: Humana Press, 2002. http://dx.doi.org/10.1385/1592593232.
Pełny tekst źródłaDriscoll, Barbara. Lung Cancer. New Jersey: Humana Press, 2002. http://dx.doi.org/10.1385/1592593240.
Pełny tekst źródłaFalk, Stephen A. Lung cancer. New York: Oxford University Press, 2009.
Znajdź pełny tekst źródłaSantiago-Cardona, Pedro G., red. Lung Cancer. New York, NY: Springer US, 2021. http://dx.doi.org/10.1007/978-1-0716-1278-1.
Pełny tekst źródłaChiang, Anne C., i Roy S. Herbst, red. Lung Cancer. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-74028-3.
Pełny tekst źródłaLeary, Alison, red. Lung Cancer. West Sussex, UK: John Wiley & Sons, Ltd., 2012. http://dx.doi.org/10.1002/9781118702857.
Pełny tekst źródłaCzęści książek na temat "Lung cancer"
Bhatia, Sujata K. "Lung Cancer Chapter 9 Lung cancer". W Biomaterials for Clinical Applications, 183–211. New York, NY: Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-6920-0_9.
Pełny tekst źródłaWorden, Francis P., i Gregory P. Kalemkerian. "Lung Cancer". W Cancer Treatment and Research, 183–219. Boston, MA: Springer US, 2001. http://dx.doi.org/10.1007/978-1-4615-1657-6_8.
Pełny tekst źródłaYamamoto, Naoyoshi, i Mio Nakajima. "Lung Cancer". W Carbon-Ion Radiotherapy, 177–89. Tokyo: Springer Japan, 2013. http://dx.doi.org/10.1007/978-4-431-54457-9_21.
Pełny tekst źródłaShah, Alap, i Daniel Hunter-Smith. "Lung Cancer". W Family Medicine, 1103–10. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-04414-9_92.
Pełny tekst źródłaWedding, Ulrich. "Lung Cancer". W Cancer and Aging Handbook, 283–314. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2013. http://dx.doi.org/10.1002/9781118312513.ch20.
Pełny tekst źródłaDobra, Katalin, i Anders Hjerpe. "Lung Cancer". W Serous Effusions, 171–89. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76478-8_8.
Pełny tekst źródłaDobra, Katalin, i Anders Hjerpe. "Lung Cancer". W Serous Effusions, 151–65. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-697-9_8.
Pełny tekst źródłaZimmermann, Stefan, Alessandra Curioni Fontecedro, Rolf A. Stahel i Solange Peters. "Lung Cancer". W Side Effects of Medical Cancer Therapy, 119–38. London: Springer London, 2012. http://dx.doi.org/10.1007/978-0-85729-787-7_3.
Pełny tekst źródłaBeyzadeoglu, Murat, Gokhan Ozyigit, Ugur Selek i Ugur Selek. "Lung Cancer". W Radiation Oncology, 251–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27988-1_6.
Pełny tekst źródłaNestle, Ursula, Sonja Adebahr i Tanja Schimek-Jasch. "Lung Cancer". W Target Volume Definition in Radiation Oncology, 91–113. Berlin, Heidelberg: Springer Berlin Heidelberg, 2015. http://dx.doi.org/10.1007/978-3-662-45934-8_5.
Pełny tekst źródłaStreszczenia konferencji na temat "Lung cancer"
Patel, Sagar S., Ramesh Natarajan i Rebecca L. Heise. "Mechanotransduction of Primary Cilia in Lung Adenocarcinoma". W ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80435.
Pełny tekst źródłaHider, Nabilah Hanani, Anis Salwa Binti Mohd Khairuddin i Effariza Binti Hanafi. "VGG Classification Model for Lung Cancer Diagnosis". W International Technical Postgraduate Conference 2022. AIJR Publisher, 2022. http://dx.doi.org/10.21467/proceedings.141.9.
Pełny tekst źródłaOlsson, A., i H. Kromhout. "OCCUPATIONAL CANCER BURDEN: THE CONTRIBUTION OF EXPOSURE TO PROCESS-GENERATED SUBSTANCES AT THE WORKPLACE". W The 16th «OCCUPATION and HEALTH» Russian National Congress with International Participation (OHRNC-2021). FSBSI “IRIOH”, 2021. http://dx.doi.org/10.31089/978-5-6042929-2-1-2021-1-617-620.
Pełny tekst źródłaSaghir, Zaigham, i Constance de Koning. "Lung cancer screening in Denmark". W Nordic Lung Congress 2022, redaktorzy Zaigham Saghir i Vibeke Backer. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/6c4e8d8d.
Pełny tekst źródłaLudeke, D. Taylor, i Maj Dedin Mirmirani. "The Pulling Device for a Flexible Bronchoscope". W ASME 2006 Frontiers in Biomedical Devices Conference. ASMEDC, 2006. http://dx.doi.org/10.1115/nanobio2006-18045.
Pełny tekst źródła"Lung Cancer Prediction Using Machine Learning: A Systematic Review". W International Conference on Women Researchers in Electronics and Computing. AIJR Publisher, 2021. http://dx.doi.org/10.21467/proceedings.114.3.
Pełny tekst źródłaGarg, Priya, i Deepti Aggarwal. "Application of Swarm-Based Feature Selection and Extreme Learning Machines in Lung Cancer Risk Prediction". W Intelligent Computing and Technologies Conference. AIJR Publisher, 2021. http://dx.doi.org/10.21467/proceedings.115.1.
Pełny tekst źródłaVengoechea, Jose Javier, Manuel Ponce-Alonso, Ana Lucía Figueredo, Elisa Mincholé, Rosa Del Campo i Salvador Bello. "Lung Micobiome in Lung Cancer". W ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1770.
Pełny tekst źródłaBaum, Philip, i Marten Dooper. "Decline in lung cancer mortality is almost exclusive to men". W European Lung Cancer Congress 2022, redaktor Stefan Rauh. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/b3865180.
Pełny tekst źródłaKäsmann, Lukas, i Marten Dooper. "No improved prognosis for concurrent versus sequential immune checkpoint inhibition and CRT in unresectable NSCLC". W European Lung Cancer Congress 2022, redaktor Stefan Rauh. Baarn, the Netherlands: Medicom Medical Publishers, 2022. http://dx.doi.org/10.55788/3640a321.
Pełny tekst źródłaRaporty organizacyjne na temat "Lung cancer"
Freire, Mariana, Diana Martins, Maria Filomena Botelho i Fernando Mendes. Biomarkers of resistance mechanisms in innovative lung cancer treatments - A systematic Review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, wrzesień 2022. http://dx.doi.org/10.37766/inplasy2022.9.0011.
Pełny tekst źródłaWang, Yan, Wenpeng Song, Sicheng Zhou, Jie Tian, Yingxian Dong, Jue Li, Junke Chang i in. Increased risk for subsequent primary lung cancer among female hormone-related cancer patients: a meta-analysis based on over four million cases. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, lipiec 2022. http://dx.doi.org/10.37766/inplasy2022.7.0044.
Pełny tekst źródłaDanny Colombara, Danny Colombara. Viral Causes of Lung Cancer. Experiment, grudzień 2012. http://dx.doi.org/10.18258/0065.
Pełny tekst źródłaKang, Jing, Jun Zhang, Zongsheng Tian, Ye Xu, Jiangbi Li i Mingxina Li. The efficacy and safety of immune-checkpoint inhibitor plus chemotherapy versus chemotherapy for non-small cell lung cancer: an updated systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, maj 2022. http://dx.doi.org/10.37766/inplasy2022.5.0156.
Pełny tekst źródłaGilbert, Jennifer, Stephanie Veazie, Kevin Joines, Kara Winchell, Rose Relevo, Robin Paynter i Jeanne-Marie Guise. Patient Navigation Models for Lung Cancer. Agency for Healthcare Research and Quality (AHRQ), grudzień 2018. http://dx.doi.org/10.23970/ahrqepcrapidlung.
Pełny tekst źródłaPanyam, Jayanth. Targeted Magnetic Hyperthermia for Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2012. http://dx.doi.org/10.21236/ada568987.
Pełny tekst źródłaPanyam, Jayanth. Targeted Magnetic Hyperthermia for Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, wrzesień 2013. http://dx.doi.org/10.21236/ada592043.
Pełny tekst źródłaGrando, Sergei. Nicotinic Receptor Polymorphism in Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, październik 2013. http://dx.doi.org/10.21236/ada598342.
Pełny tekst źródłaPanyam, Jayanth. Targeted Magnetic Hyperthermia for Lung Cancer. Fort Belvoir, VA: Defense Technical Information Center, listopad 2014. http://dx.doi.org/10.21236/ada620276.
Pełny tekst źródłaLiu, JIe, Xu-li Yang, Xing Liu, Yan Xu i He-lang Huang. Predictors of readmission after pulmonary resection in patients with lung cancer. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, październik 2022. http://dx.doi.org/10.37766/inplasy2022.10.0049.
Pełny tekst źródła